Piramal Enterprise
- All
- News
-
Why Is Piramal Enterprises Share Price Falling?
These three reasons have sent the share price of Piramal Enterprises down by 26% this year.
-
Piramal Enterprises Shares Hit 52-Week Low, Down 10% After Earnings Report
Shares of Piramal Enterprises Ltd fell to its 52-week low, down nearly 10 per cent on Friday, a day after reporting a consolidated net profit of Rs 150.53 crore in the March quarter.
-
Piramal Enterprises To Demerge And List Pharma Business
Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate structure.
-
Piramal Group Acquires DHFL For Rs 34,250 Crore
The Piramal Group paid Rs 38,000 crore to the aggregators of of DHFL - which includes Rs 34,250 crore to be paid by Piramal Capital and Housing Finance in cash and non-convertible debentures (NCDs), and Rs 3,800 crore from the cash balance available with the DHFL.
-
Stocks To Watch: Infosys, TCS, Piramal Enterprises
Infosys and The Economist Group have announced a new strategic partnership to enable and accelerate sustainability solutions and drive world-changing impact
-
Piramal Group Receives Nod For DHFL Resolution Plan; Stock Soars Over 6%
Dewan Housing Finance shares would be delisted from stock exchanges post the acquisition by Piramal Capital and Housing Finance
-
Billionaire Ajay Piramal's Conglomerate Wins Bid For Bankrupt Shadow Lender DHFC
A resolution plan for Dewan from Piramal Enterprises' own shadow bank, Piramal Capital & Housing Finance was approved by Dewan's committee of creditors in a vote on Friday
-
Dewan Housing Finance Surges 5% As Piramal Group Wins Acquisition Bid
Once one of the country's top non-banking finance company, DHFL, accumulated total debts of almost Rs 1 lakh crore before defaulting on payments to its creditors
-
Piramal Enterprises Shares Jump After US-Based Carlyle Buys Stake In Pharma Unit
Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.
-
US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore
Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.
-
Piramal Enterprises Divests DRG Business For $950 Million
"Piramal Enterprises Limited today announced that PEL DRG Dutch HoldCo BV, a 100 per cent subsidiary of PEL and the holding company for DRG... has signed a definitive agreement for the sale of DRG to Clarivate Analytics plc, a global leader in providing trusted insights and analytics, for a sale consideration of US$950 million," the company said in...
-
Piramal Enterprises To Raise Rs 2,750 Crore By Issuing Bonds
The company's announcement comes close to the date by when the group needs to pay ASAN Corporate Solutions' debt of Rs 1,350 crore.
-
Piramal Enterprises, Canadian Pension Fund Set Up $600-Million Renewable Energy Trust
The remaining amount will be raised from other investors, Mumbai-based Piramal said
-
Saridon Exempted From List Of Banned Medicines By Top Court, Says Company
Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.
-
Supreme Court Exempts Saridon From List Of Banned Drugs; Piramal Enterprises Rises
Saridon is amongst the country's most widely distributed analgesic tablets with a strong distribution network across 9 lakh outlets, and enjoys strong customer allegiance globally, Piramal Enterprises said, adding that the popularity of the brand is widespread with 31 tablets being sold every second.
-
Why Is Piramal Enterprises Share Price Falling?
These three reasons have sent the share price of Piramal Enterprises down by 26% this year.
-
Piramal Enterprises Shares Hit 52-Week Low, Down 10% After Earnings Report
Shares of Piramal Enterprises Ltd fell to its 52-week low, down nearly 10 per cent on Friday, a day after reporting a consolidated net profit of Rs 150.53 crore in the March quarter.
-
Piramal Enterprises To Demerge And List Pharma Business
Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate structure.
-
Piramal Group Acquires DHFL For Rs 34,250 Crore
The Piramal Group paid Rs 38,000 crore to the aggregators of of DHFL - which includes Rs 34,250 crore to be paid by Piramal Capital and Housing Finance in cash and non-convertible debentures (NCDs), and Rs 3,800 crore from the cash balance available with the DHFL.
-
Stocks To Watch: Infosys, TCS, Piramal Enterprises
Infosys and The Economist Group have announced a new strategic partnership to enable and accelerate sustainability solutions and drive world-changing impact
-
Piramal Group Receives Nod For DHFL Resolution Plan; Stock Soars Over 6%
Dewan Housing Finance shares would be delisted from stock exchanges post the acquisition by Piramal Capital and Housing Finance
-
Billionaire Ajay Piramal's Conglomerate Wins Bid For Bankrupt Shadow Lender DHFC
A resolution plan for Dewan from Piramal Enterprises' own shadow bank, Piramal Capital & Housing Finance was approved by Dewan's committee of creditors in a vote on Friday
-
Dewan Housing Finance Surges 5% As Piramal Group Wins Acquisition Bid
Once one of the country's top non-banking finance company, DHFL, accumulated total debts of almost Rs 1 lakh crore before defaulting on payments to its creditors
-
Piramal Enterprises Shares Jump After US-Based Carlyle Buys Stake In Pharma Unit
Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.
-
US-Based Carlyle Buys 20% Stake In Piramal Enterprises' Pharma Business For Rs 3,700 Crore
Piramal Pharma will use the capital raised through the dealto accelerate its organic and inorganic growth plans.
-
Piramal Enterprises Divests DRG Business For $950 Million
"Piramal Enterprises Limited today announced that PEL DRG Dutch HoldCo BV, a 100 per cent subsidiary of PEL and the holding company for DRG... has signed a definitive agreement for the sale of DRG to Clarivate Analytics plc, a global leader in providing trusted insights and analytics, for a sale consideration of US$950 million," the company said in...
-
Piramal Enterprises To Raise Rs 2,750 Crore By Issuing Bonds
The company's announcement comes close to the date by when the group needs to pay ASAN Corporate Solutions' debt of Rs 1,350 crore.
-
Piramal Enterprises, Canadian Pension Fund Set Up $600-Million Renewable Energy Trust
The remaining amount will be raised from other investors, Mumbai-based Piramal said
-
Saridon Exempted From List Of Banned Medicines By Top Court, Says Company
Pharma major Piramal Enterprises on Thursday said Saridon, its pain relief tablet, has been exempted from the list of banned fixed dose combinations (FDCs) by the Supreme Court.
-
Supreme Court Exempts Saridon From List Of Banned Drugs; Piramal Enterprises Rises
Saridon is amongst the country's most widely distributed analgesic tablets with a strong distribution network across 9 lakh outlets, and enjoys strong customer allegiance globally, Piramal Enterprises said, adding that the popularity of the brand is widespread with 31 tablets being sold every second.
